» Articles » PMID: 29791944

The Global Burden of Headache

Overview
Journal Semin Neurol
Specialty Neurology
Date 2018 May 24
PMID 29791944
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

At the turn of the century, most of the world's population lived in regions where the prevalence of headache was unknown and its impact poorly understood. Lifting The Burden (LTB), a nonprofit organization in official relations with the World Health Organization, established the Global Campaign against Headache, with the ultimate purpose of reducing the burden of headache worldwide. First, the scope and scale of this burden had to be known. LTB embarked upon a program of population-based studies in countries in all world regions in order to achieve its aim. Its studies have demonstrated a high prevalence of headache disorders, including migraine, tension-type headache, and medication-overuse headache, and their associations with impaired quality of life, substantial lost productivity, and high economic costs in every country surveyed. Informed by these, the Global Burden of Disease study ranks headache disorders as the second leading cause of years lived with disability worldwide; migraine alone is third among people aged 15 to 49 years. With interventions urgently needed to reduce these burdens throughout the world, we review the epidemiological studies conducted by LTB, examine proposed interventions to improve provision of headache care including a three-tier system of structured headache services, and consider the challenges still remaining in providing effective, efficient, and equitable headache care especially in low-income countries.

Citing Articles

Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus.

Kourlaba G, Vikelis M, Karapanayiotides T, Solakidi A, Trafalis D, Lioliou K Front Neurol. 2025; 16:1556808.

PMID: 40040919 PMC: 11878100. DOI: 10.3389/fneur.2025.1556808.


Psychiatric comorbidity in patients with migraine: A standardized interview-based study.

Sharma P, Kumar S, Dixit V, Sharma C, Chaudhury S Ind Psychiatry J. 2025; 33(2):266-274.

PMID: 39898097 PMC: 11784700. DOI: 10.4103/ipj.ipj_60_23.


Impact of Headache and Over-the-Counter Treatment on Pain and Functional and Cognitive Parameters: A Real-World Study across Three Geographies.

Goadsby P, Straube A, Shibata M, Peres M, Amand C, Colby C Pain Ther. 2025; .

PMID: 39891825 DOI: 10.1007/s40122-024-00703-5.


A Literature Review of the Educational Gaps and Needs in Migraine Management: An Asian Perspective Within a Global Context.

Ching S, Yong F, Jao H, Santiago-Dayanghirang J, Shinde S, Setia S Cureus. 2024; 16(12):e75337.

PMID: 39649235 PMC: 11625493. DOI: 10.7759/cureus.75337.


Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review.

Lipton R, Gendolla A, Abraham L, Jenkins A, Telfort J, Blakeman K Headache. 2024; 65(1):164-179.

PMID: 39601097 PMC: 11726002. DOI: 10.1111/head.14854.